You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cardiotoxicity

Showing 1 - 25 of 551
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Checkpoint Inhibitor-related Cardiotoxicity

Not yet recruiting
  • Immune Checkpoint Inhibitors, Cardiotoxicity
  • Cardiac magnetic resonance
  • (no location specified)
Nov 10, 2023

Chemotherapy-induced Cardiotoxicity.

Recruiting
  • Cardiotoxicity
  • +2 more
  • Blood sampling
  • +4 more
  • Prague, Czechia
  • +1 more
Aug 15, 2023

Cardiotoxicity, Tumors, Chemo Effect Trial in São Paulo (Spironolactone, Placebo)

Not yet recruiting
  • Cardiotoxicity
  • +3 more
  • São Paulo, Brazil
    Instituto do Coração
Aug 16, 2023

Breast Cancer, Doxorubicin Induced Cardiotoxicity Trial in Damanhur (Placebo, Montelukast)

Recruiting
  • Breast Cancer
  • Doxorubicin Induced Cardiotoxicity
  • Damanhūr, Elbehairah, Egypt
    Damanhour Oncology Center
Jul 16, 2023

Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)

Recruiting
  • Doxorubicin Induced Cardiomyopathy
  • Atorvastatin 40 Mg Oral Tablet
  • Placebo
  • Cairo, Egypt
    Ain Shams University hospitals
Apr 4, 2023

Cancer Treatment-Related Cardiotoxicity

Completed
  • Cardiotoxicity
    • Minneapolis, Minnesota
      University of Minnesota
    Oct 15, 2022

    Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)

    Not yet recruiting
    • Breast Cancer Stage 2 and 3
    • (no location specified)
    Nov 24, 2023

    Cardiotoxicity Trial in Moscow (Remote 1-minute single-lead electrocardiogram (ECG) monitoring in cancer patients after the

    Recruiting
    • Cardiotoxicity
    • Remote 1-minute single-lead electrocardiogram (ECG) monitoring in cancer patients after the first polychemotherapy cycle.
    • Moscow, Russian Federation
      I.M. Sechenov First Moscow State Medical University (Sechenov Un
    Jan 7, 2023

    Cancer, Heart Failure, Arrhythmia Trial in Harbin (Control group:DH001 , Trial group: DH001 low-dose group, Trial group: DH001

    Recruiting
    • Cancer
    • +4 more
    • Control group:DH001 placebo
    • +2 more
    • Harbin, Heilongjiang, China
      Harbin Institute of Hematology and Cancer
    Oct 20, 2023

    Social Determinants of Cardiotoxicity in Prostate Cancer

    Recruiting
    • Prostate Cancer
    • +3 more
    • Social Determinants of Health
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jan 19, 2023

    Social Determinants of Cardiotoxicity in Breast Cancer

    Recruiting
    • Breast Cancer
    • +3 more
    • Social Determinants of Health
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jan 19, 2023

    Cardiotoxic Medication Use Due to Sodium Arsenite Chloride

    Recruiting
    • Adverse Reaction
    • +2 more
    • Sodium arsenite chloride injection
    • Jinan, Shandong, China
    • +1 more
    Sep 23, 2023

    Late Anthracycline Induced Cardiotoxicity- Childhood Cancer

    Recruiting
    • Anthracycline Induced Cardiotoxicity
      • Belfast, United Kingdom
        Belfast Health and Social Care Trust
      Sep 7, 2022

      Chemotherapeutic Toxicity, Cardiotoxicity, Heart Failure Trial in Tainan (Prevention therapy, Rescue therapy)

      Recruiting
      • Chemotherapeutic Toxicity
      • +4 more
      • Prevention therapy
      • Rescue therapy
      • Tainan, Taiwan
        National Cheng Kung University Hospital
      Jun 6, 2023

      Tumors Trial in San Diego (low dose CT)

      Completed
      • Neoplasms
      • low dose CT
      • San Diego, California
        University of California San Diego Medical Center
      Nov 1, 2022

      Thoracic Cancer, Left Sided Breast Cancer Trial in Dallas ([1-13C]pyruvate along with MRI imaging)

      Suspended
      • Thoracic Cancer
      • Left Sided Breast Cancer
      • [1-13C]pyruvate along with MRI imaging
      • Dallas, Texas
        Department of Radiation Oncology; UT Southwestern Medical Center
      Nov 14, 2022

      sociated Cardiotoxicity Basing on PET/CT in Lymphoma

      Not yet recruiting
      • Positron-Emission Tomography
        • (no location specified)
        Jun 6, 2022

        Cancer Trial in São Paulo (Carvedilol, Placebo)

        Recruiting
        • Cancer
        • São Paulo, Sao Paulo, Brazil
          Hospital Sirio Libanes
        Sep 20, 2022

        Breast Cancer, Myocardial Damage, Cardiotoxicity Trial in Dusseldorf (Cardiac MRI and echocardiography, laboratory parameters)

        Completed
        • Breast Cancer
        • +2 more
        • Cardiac MRI and echocardiography, laboratory parameters
        • Dusseldorf, Germany
          Division of Cardiology, Pulmonary Disease and Vascular Medicine
        May 19, 2022

        Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated

        Enrolling by invitation
        • Cardiotoxicity
        • +3 more
        • Chemoradiation
        • Birmingham, Alabama
        • +6 more
        Nov 1, 2022

        Chemo-induced Cardiotoxicity, Breast Cancer Trial in Tanta (Rosuvastatin 20mg)

        Recruiting
        • Chemotherapy-induced Cardiotoxicity
        • Breast Cancer
        • Rosuvastatin 20mg
        • Tanta, Egypt
          The Department of Clinical Oncology, Tanta University Hospital
        Apr 18, 2022

        Developing Cardiotoxicity After Receiving Chemotherapy for

        Recruiting
        • Breast Cancer
        • +2 more
        • Cardiac Imaging
        • Data Collection
        • Montréal, Quebec, Canada
        • +2 more
        Dec 20, 2022

        Breast Cancer, Lymphoma, Large B-Cell, Diffuse, Cardiotoxicity Trial in Rozzano (Nebivolol, Placebo)

        Active, not recruiting
        • Breast Cancer
        • +4 more
        • Rozzano, Milan, Italy
          IRCCS Humanitas Research Hospital
        Feb 5, 2023

        Atherosclerosis in Chemotherapy-related Cardiotoxicity

        Recruiting
        • Cardiotoxicity
        • Atherosclerosis
        • echocardiography, computed tomography
        • Warsaw, Poland
          National Institute of Oncology
        Feb 20, 2022

        Cardiac Functioning: a Longitudinal Study

        Recruiting
        • Neoplasm, Breast
        • +3 more
        • Echocardiography
        • Groningen, Netherlands
          University Medical Center Groningen
        May 5, 2023